These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36648742)

  • 1. Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome.
    Lai X; Cui Z; Zhang H; Zhang YM; Wang F; Wang X; Meng LQ; Cheng XY; Liu G; Zhao MH
    Int Urol Nephrol; 2023 Jun; 55(6):1565-1574. PubMed ID: 36648742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantifying relationship between the remission duration and the cardiovascular and kidney outcomes in the patients with primary nephrotic syndrome.
    Lai X; Cui Z; Zhang H; Zhang YM; Wang F; Wang X; Meng LQ; Cheng XY; Liu G; Zhao MH
    Ren Fail; 2022 Dec; 44(1):1915-1923. PubMed ID: 36369936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort.
    Fu L; Tai S; Sun J; Zhang N; Zhou Y; Xing Z; Wang Y; Zhou S
    Diabetes Care; 2022 Sep; 45(9):2136-2143. PubMed ID: 35834242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Hsu WH; Lai CW; Chen SC; Chiou HC; Hsiao PJ; Shin SJ; Lee MY
    Endocr Pract; 2019 Sep; 25(9):918-925. PubMed ID: 31070951
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.
    Segar MW; Patel RB; Patel KV; Fudim M; DeVore AD; Martens P; Hedayati SS; Grodin JL; Tang WHW; Pandey A
    JAMA Cardiol; 2021 Jan; 6(1):68-77. PubMed ID: 33206129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.
    Bangalore S; Breazna A; DeMicco DA; Wun CC; Messerli FH;
    J Am Coll Cardiol; 2015 Apr; 65(15):1539-48. PubMed ID: 25881936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
    J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease.
    Chamberlain AM; Cohen SS; Weston SA; Fox KM; Xiang P; Killian JM; Qian Y
    Am J Cardiol; 2019 Jun; 123(11):1739-1744. PubMed ID: 30948001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between low-density and non-high-density lipoprotein cholesterol with incident cardiovascular disease among low-risk Iranians during 2 decades follow-up.
    Tohidi M; Asgari S; Chary A; Azizi F; Hadaegh F
    Clin Biochem; 2022; 109-110():28-36. PubMed ID: 35970222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study.
    Yun SY; Rim JH; Kang H; Lee SG; Lim JB
    Ann Lab Med; 2023 May; 43(3):237-243. PubMed ID: 36544335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
    Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Related Associations of Low-Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Cohort Study.
    Jung HN; Kim MJ; Kim HS; Lee WJ; Min SH; Kim YJ; Jung CH
    J Am Heart Assoc; 2022 May; 11(9):e024637. PubMed ID: 35492003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study.
    Boey E; Gay GM; Poh KK; Yeo TC; Tan HC; Lee CH
    Atherosclerosis; 2016 Jan; 244():86-92. PubMed ID: 26595903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts.
    Hilvo M; Dhar I; Lääperi M; Lysne V; Sulo G; Tell GS; Jousilahti P; Nygård OK; Brenner H; Schöttker B; Laaksonen R
    Eur J Prev Cardiol; 2022 Mar; 29(3):e128-e137. PubMed ID: 34060615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL-C/HDL-C ratio and risk of all-cause mortality in patients with intracerebral hemorrhage.
    You S; Zhong C; Xu J; Han Q; Zhang X; Liu H; Zhang Y; Shi J; Huang Z; Xiao G; Zhang C; Cao Y; Liu C
    Neurol Res; 2016 Oct; 38(10):903-8. PubMed ID: 27412564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
    Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
    Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
    Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
    Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.
    Gu J; Yin ZF; Pan JA; Zhang JF; Wang CQ
    Anatol J Cardiol; 2019 Sep; 22(3):117-124. PubMed ID: 31475951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.